Clínica Baviera, S.A. (BME:CBAV)
47.50
+0.50 (1.06%)
At close: Dec 5, 2025
Clínica Baviera Revenue
Clínica Baviera had revenue of 65.30M EUR in the quarter ending September 30, 2025, with 16.55% growth. This brings the company's revenue in the last twelve months to 296.76M, up 17.54% year-over-year. In the year 2024, Clínica Baviera had annual revenue of 265.72M with 17.02% growth.
Revenue (ttm)
296.76M
Revenue Growth
+17.54%
P/S Ratio
2.56
Revenue / Employee
160.67K
Employees
1,759
Market Cap
760.57M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 265.72M | 38.66M | 17.02% |
| Dec 31, 2023 | 227.07M | 28.62M | 14.42% |
| Dec 31, 2022 | 198.45M | 25.20M | 14.55% |
| Dec 31, 2021 | 173.25M | 50.62M | 41.28% |
| Dec 31, 2020 | 122.63M | -1.71M | -1.37% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grifols | 7.52B |
| Laboratorios Farmaceuticos Rovi | 724.20M |
| Almirall | 1.09B |
| Faes Farma | 571.12M |
| Pharma Mar | 179.28M |
| Oryzon Genomics | 7.36M |
| Prim, S.A. | 240.68M |
| Laboratorio Reig Jofre | 330.34M |